MED31 anticorps (N-Term)
-
- Antigène Voir toutes MED31 Anticorps
- MED31 (Mediator Complex Subunit 31 (MED31))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MED31 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- MED31 antibody was raised against the N terminal of MED31
- Purification
- Affinity purified
- Immunogène
- MED31 antibody was raised using the N terminal of MED31 corresponding to a region with amino acids MAAAVAMETDDAGNRLRFQLELEFVQCLANPNYLNFLAQRGYFKDKAFVN
- Top Product
- Discover our top product MED31 Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
MED31 Blocking Peptide, catalog no. 33R-5587, is also available for use as a blocking control in assays to test for specificity of this MED31 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MED31 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- MED31 (Mediator Complex Subunit 31 (MED31))
- Autre désignation
- MED31 (MED31 Produits)
- Synonymes
- anticorps 3110004H13Rik, anticorps Soh1, anticorps CGI-125, anticorps l11Jus15, anticorps RGD1309457, anticorps fa04d01, anticorps zgc:92673, anticorps wu:fa04d01, anticorps CaO19.1429, anticorps cgi-125, anticorps med31, anticorps med31-a, anticorps med31-b, anticorps med31a, anticorps soh1, anticorps soh1-A, anticorps mediator complex subunit 31, anticorps Soh1p, anticorps mediator complex subunit Med31, anticorps mediator complex subunit 31 L homeolog, anticorps MED31, anticorps Med31, anticorps med31, anticorps SOH1, anticorps med31.L
- Sujet
- MED31 is the component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes.
- Poids moléculaire
- 16 kDa (MW of target protein)
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-